ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 112 filers reported holding ACCELERON PHARMA INC in Q3 2015. The put-call ratio across all filers is 2.48 and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $486,000 | -4.3% | 13,441 | -10.0% | 0.19% | -12.8% |
| Q2 2016 | $508,000 | +41.5% | 14,941 | +31.5% | 0.22% | +109.6% |
| Q2 2015 | $359,000 | -37.1% | 11,358 | -24.3% | 0.10% | -50.2% |
| Q1 2015 | $571,000 | -2.2% | 15,000 | 0.0% | 0.21% | -23.7% |
| Q4 2014 | $584,000 | +28.6% | 15,000 | 0.0% | 0.27% | +21.2% |
| Q3 2014 | $454,000 | -11.0% | 15,000 | 0.0% | 0.23% | -35.6% |
| Q2 2014 | $510,000 | -48.7% | 15,000 | -47.9% | 0.35% | -50.6% |
| Q1 2014 | $994,000 | -16.3% | 28,800 | -4.0% | 0.71% | +260.9% |
| Q4 2013 | $1,188,000 | – | 30,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |